EC
IART icon

Elequin Capital’s Integra LifeSciences IART Stock Holding History

Elequin Capital’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2
Closed -$45 – 469
2024
Q4 		$45 Sell
2
-1,148
-100% -$25.1K ﹤0.01% 502
2024
Q3 		$20.9K Buy
+1,150
New +$26.7K ﹤0.01% 154
2024
Q2 		– Sell
-43
Closed -$1.52K – 263
2024
Q1 		$1.52K Buy
+43
New +$1.72K ﹤0.01% 188
2023
Q3 		– Sell
-90
Closed -$3.7K – 498
2023
Q2 		$3.7K Buy
+90
New +$4.33K ﹤0.01% 400
2022
Q3 		– Sell
-221
Closed -$12K – 609
2022
Q2 		$12K Sell
221
-57
-21% -$3.42K ﹤0.01% 222
2022
Q1 		$18K Buy
+278
New +$18.3K ﹤0.01% 127

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Elequin Capital's IART Position: Q1 2025 in Review

Elequin Capital sold out of Integra LifeSciences (IART) in Q1 2025, closing a stake of 2 shares — an estimated $45 sold.

Elequin Capital first reported a position in IART in Q1 2022 and held it in 6 quarters. The position peaked at $20.9K in Q3 2024. 219 funds tracked by Wall St. Rank hold IART as of Q1 2025.

  • Elequin Capital reported no remaining Integra LifeSciences position as of Q1 2025 after selling out during the quarter.
  • Elequin Capital sold 2 Integra LifeSciences shares in Q1 2025, an estimated $45.
  • Elequin Capital first reported a position in Integra LifeSciences in Q1 2022 and held it in 6 quarters.
  • Elequin Capital's Integra LifeSciences position peaked at $20.9K in Q3 2024.
  • 219 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2025.

Based on Elequin Capital's 13F filing for Q1 2025, filed 13 May 2025.